Editorial Team
Editorial
Articles are researched, written, and reviewed by the Myostatin Inhibitors Hub editorial team. Drafts are checked against primary literature and clinical-trial registries before publishing.
Articles
58
Activin E (INHBE): The Liver Hormone Behind the Next Obesity Drugs
Activin E is the liver-made cousin of myostatin and activin A. People born with low activin E carry less belly fat and get diabetes less often, and three biotechs are now silencing it to copy that effect.
Trevogrumab: The Regeneron Myostatin Blocker Behind COURAGE
Trevogrumab is Regeneron's anti-myostatin antibody. In the COURAGE trial it cut the muscle loss people normally suffer on semaglutide roughly in half, and a three-drug version preserved 81 percent of lean mass. Here is the data, the safety trade-off, and why you cannot buy it.
Exercises That Lower Myostatin: What the Studies Actually Show
Most articles promising myostatin-lowering exercises are recycling the same three bullet points. The real list is shorter, the timing matters more, and one common piece of advice is wrong.
Protein Intake and Myostatin: Does High-Protein Eating Lower It?
More protein does not lower myostatin the way the bro-science suggests. In one trial, post-training plasma myostatin actually tripled in the high-protein group. The mechanism is subtler — and the per-meal dose matters more than the daily total.
How Resistance Training Suppresses Myostatin (and for How Long)
Heavy training raises myostatin acutely and lowers it chronically. The timing matters: at 4 hours post-workout, your numbers look bad. At 8 weeks, they look great.
Fasting, Autophagy, and Myostatin: Does Skipping Meals Raise It?
Short fasts probably don't move myostatin much. Forty-hour fasts and prolonged calorie restriction do. The difference is whether autophagy and amino acid scarcity reach the threshold that flips muscle into protection mode.
Sleep, Cortisol, and Myostatin: Why Poor Sleep Stalls Gains
Six hours of sleep raises evening cortisol, blunts the testosterone wake-up, and leaves your training response stuck in the catabolic half of the cycle. The myostatin angle is just the most measurable part.
Testosterone and Myostatin: How TRT Lowers GDF-8
Testosterone is a myostatin suppressor. In hypogonadal men, six months of TRT drops muscle myostatin expression by roughly 29% while doubling FGF2 and raising IGF-1 — the molecular reason TRT actually moves body composition.
What Bed Rest Does to Your Myostatin (and Muscle)
Bed rest is not rest. After three days of immobility, myostatin transcription climbs, atrogenes light up, and muscle starts breaking down faster than calories can fix.
Myostatin and Heart Failure: Cardiac vs Skeletal Muscle
Myostatin behaves differently in cardiac muscle than in skeletal muscle. The failing heart secretes it. Skeletal muscle gets the worst of it. Blocking it everywhere is harder than it sounds.
Myostatin, Insulin Resistance, and Type 2 Diabetes
Myostatin is a muscle gene, but its effects spill into insulin signaling, glucose uptake, and metabolic syndrome. People with high serum myostatin look insulin-resistant before the diabetes label arrives.
Myostatin in Chronic Kidney Disease: The Dialysis Muscle-Loss Connection
CKD does not just damage kidneys. It rewires muscle protein turnover through a uremic environment that drives myostatin up, IGF-1 down, and lean mass into ongoing decline.
Myostatin and Cancer Cachexia: Why Muscle Wasting Resists Calories
Cancer cachexia is not starvation. Patients who eat enough still lose muscle, and myostatin and its sibling activin A are central to why food alone cannot stop it.
Myostatin and Duchenne Muscular Dystrophy: What the Trials Showed
Duchenne muscular dystrophy was supposed to be the disease that proved myostatin inhibitors. Eight programs, three sponsors, and one common failure pattern later, the field is still trying.
Trichostatin A and Myostatin: Why This HDAC Inhibitor Raises Myostatin, Not Lowers It
Trichostatin A and myostatin tell a counter-intuitive story: TSA, a popular HDAC inhibitor, transcriptionally activates myostatin in muscle cells.
YK-11: Does the \"Myostatin SARM\" Actually Inhibit Myostatin?
YK-11 is sold as a myostatin-inhibiting SARM, but the chemistry, the source study, and the side-effect record tell a different story. Here is what the evidence really shows.
Where to Buy Follistatin: Vendor Comparison and Red Flags
Where to buy follistatin is the easy question. Reading a vendor's COA, purity claim, and price math is the hard one. Here is the honest comparison.
Myostatin Deficiency in Humans: The German Baby, Liam Hoekstra, and What the Gene Does
Myostatin deficiency in humans is rare, real, and often oversold. A German baby, an American toddler, and a 2026 UK Biobank study now anchor what we actually know.
Myostatin and Aging: How GDF-8 Changes From Your 30s to Your 70s
Myostatin and aging is not a clean upward line. Lean mass drops, anabolic resistance climbs, and GDF-8 only tells part of the sarcopenia story.
Myostatin in Women: Why Female Muscle Biology Reads Differently
Myostatin in women behaves differently than the gym-bro story suggests. Reproduction, the menstrual cycle, PCOS, and menopause all shift the picture.
Myostatin Blood Test: Where to Get One and What the Result Means
A myostatin blood test sounds straightforward, but the assays measure different things, the reference ranges are shaky, and the most useful number is the follistatin-to-myostatin ratio. Here is what each available option actually delivers.
Sotatercept and the Activin Pathway: Beyond Myostatin
Sotatercept (Winrevair) is an ActRIIA-Fc fusion that started as a muscle drug, became the first activin-signaling inhibitor approved for pulmonary arterial hypertension, and proves that traps in this pathway can save lives outside the muscle field.
Garetosmab and FOP: Regeneron's Activin A Blocker Explained
Garetosmab is Regeneron's activin A antibody for fibrodysplasia ossificans progressiva. Inside the OPTIMA Phase 3 trial, the 94% reduction in new bone lesions, the FDA priority review, and how it ties back to myostatin pathway biology.
Taldefgrobep Alfa: Biohaven's Bet on Muscle-Preserving Weight Loss
Taldefgrobep alfa missed its SMA primary endpoint, but its body-composition data was strong enough to relaunch Biohaven as a contender in the muscle-sparing obesity race. Here is the full status as of May 2026.
ACE-031 (Ramatercept): Why the Original Myostatin Drug Failed
ACE-031 was the first ActRIIB-Fc trap to reach DMD trials. Inside the real Acceleron history, the epistaxis and telangiectasia that ended Phase 2, the ramatercept rename, and why peptide vendors selling 'ACE-031' are not selling the same molecule.
Myostatin Inhibitors and Obesity: The New Class of Weight-Loss Drugs
Myostatin inhibitors became the new obesity story because GLP-1 drugs strip too much muscle. Here is the full 2026 pipeline: bimagrumab, apitegromab, trevogrumab, taldefgrobep, and the realistic limits.
Myostatin and Sarcopenia: Why Muscle Loss Accelerates After 60
Myostatin is one of the clearest age-related muscle-loss biomarkers, and it explains why sarcopenia accelerates after 60. Here is what circulating GDF-8 actually does, what trials of myostatin drugs found, and what works right now.
Follistatin 315 vs 344: Which Version Actually Works Better?
Follistatin 315 and 344 are not interchangeable. One is local and slow-clearing, the other is systemic and converts in serum. Here is the real isoform comparison, half-life math, and how peptide market purity changes the answer.
Follistatin Side Effects: What to Watch For at Each Dose
Follistatin side effects are not just injection-site reactions. FSH suppression, tendon weakness, eye CSCR cases, liver enzymes, and cancer signaling all show up in the data. Here is the dose-by-dose risk picture and what real users report.
Follistatin Before and After: What Results Are Actually Realistic
Follistatin before and after photos online are exaggerated more often than not. Here is the honest week-by-week timeline, lean mass numbers from human data, what changes first, and what most transformation posts conveniently leave out.
How to Increase Follistatin Naturally: Food, Training, and Sleep
Most natural follistatin advice is half guessing. Here is what training, sleep, food, and a few supplements actually do — and where the ceiling sits.
Follistatin Peptide: How It Works, What It Does, and Real-World Limits
Follistatin peptide promises muscle growth by removing the myostatin brake. The pathway is real, the human peptide data is thin, and the sourcing market is messy. Here is the honest read.
Follistatin Dosage: Protocols, Cycle Length, and Why Less Is More
Follistatin dosage in plain numbers: 100 mcg per day, 10 to 30 days, with reconstitution math, dose-by-goal splits, and the missed-dose rules most articles skip.
Apitegromab: Scholar Rock's Myostatin Drug for SMA
Apitegromab is the first myostatin-targeted therapy to hit a Phase 3 endpoint in SMA. Here is what SAPPHIRE actually showed, how the drug is dosed, and where FDA review stands in 2026.
What Is Follistatin? The Body's Natural Myostatin Antagonist
Follistatin is the protein your body uses to push back against myostatin. This guide explains the isoforms, the human evidence, and what muscle-focused readers should actually do with it.
Follistatin 344: Dosage, Results, and What FST-344 Actually Does
Follistatin 344 dosage, real human evidence, FST-344 vs FST-315, side effects, and the vendor reality most articles skip. A clear read for people weighing the peptide.
Bimagrumab: The Activin Receptor Antibody Lilly Paired With Semaglutide
Bimagrumab is the ActRII antibody Lilly bought for 1.9 billion dollars. Here is the BELIEVE trial data, the JAMA T2DM results, the muscle-spasm problem, and why Lilly hit pause.
Follistatin Gene Therapy: Bryan Johnson, Minicircle, and What's Real
Follistatin gene therapy promises muscle, fat loss, and a younger biological age. Here is what the Minicircle plasmid trial, Bryan Johnson's $25,000 Honduras experiment, and the AAV gene-therapy data actually show — and where the unknowns still are.
Myostatin Inhibitors and GLP-1 Muscle Loss: What Ozempic Users Should Know
GLP-1 drugs strip muscle along with fat. This guide breaks down the real numbers, the bimagrumab plus semaglutide data, the trevogrumab COURAGE trial, taldefgrobep, and what is actually buyable in 2026.
CRISPR and Myostatin: Gene Editing, Muscle Growth, and Bodybuilding Claims
CRISPR myostatin editing is real in cells, animals, embryos, and research models, but bodybuilding biohacking claims skip the hardest safety, ethics, delivery, and legal questions.
Creatine, Vitamin D, Sulforaphane, and Other Nutrients That May Affect Myostatin
Creatine, vitamin D, sulforaphane, HMB, epicatechin, protein, and ecdysterone all appear in myostatin discussions. This evidence-led roundup separates useful nutrition from overhyped pathway claims.
Are Myostatin Inhibitors Legal? Supplements, Peptides, and Prescription Drugs
Myostatin inhibitor legality depends on the product type, intended use, sport rules, and country. This guide explains supplements, research peptides, SARMs, antibodies, prescriptions, and WADA risk.
Anti-Myostatin Antibodies and Drug Candidates: MYO-029, BMS-986089, LY2495655
Anti-myostatin antibodies include research reagents and clinical drug candidates. This guide explains MYO-029, domagrozumab, BMS-986089, LY2495655, trevogrumab, apitegromab, and what failed trials taught.
Myostatin Protein Explained: GDF-8, Signaling, and Muscle Regulation
Myostatin protein, also called GDF-8, is a muscle-made signaling protein that limits muscle growth. This guide explains its structure, activation, receptors, testing, and why claims get exaggerated.
Low Myostatin: Causes, Genetics, Symptoms, and Muscle Growth
Low myostatin can mean rare MSTN genetics, temporary blood-test changes, illness-related shifts, or marketing language. This guide explains what low myostatin does and does not prove.
Myostatin Inhibitor Reddit Claims: What Users Get Right and Wrong
Reddit myostatin inhibitor threads mix useful skepticism with supplement hype, peptide claims, YK11 talk, and genetics myths. This fact-check separates the claims from the evidence.
Myostatin Inhibitor Before and After: What Results Are Realistic?
Myostatin inhibitor before-and-after claims often exaggerate visible transformation. This guide explains realistic timelines, body-composition data, clinical results, and red flags.
Myostatin Inhibitor Peptides: Research, Mechanisms, and Safety Questions
Myostatin inhibitor peptide claims mix real research, discontinued biologics, follistatin-style products, and online vial marketing. This guide separates mechanisms, evidence, and safety limits.
Myostatin Inhibitors in Humans: What Studies Show and What They Do Not
Myostatin inhibitors in humans can increase lean mass or change body composition, but functional results are mixed. This evidence review explains the major studies and current candidates.
Epicatechin and Myostatin: Does It Really Lower Myostatin?
Epicatechin and myostatin claims sound stronger than the evidence. This review separates cocoa, green tea, supplement claims, human data, and realistic expectations.
How to Reduce Myostatin Naturally: What Actually Has Evidence?
To reduce myostatin naturally, focus on progressive resistance training, protein, creatine, sleep, recovery, and nutrient correction before chasing myostatin-labeled products.
Natural Myostatin Inhibitors: Foods, Training, and Supplements Reviewed
A natural myostatin inhibitor is usually not a magic blocker. This review ranks training, protein, creatine, epicatechin, vitamin D, HMB, and food-based options by practical evidence.
Myostatin Inhibitor Drugs: Current Pipeline and Failed Candidates
Myostatin inhibitor drugs are moving through SMA, obesity, and lean-mass trials. This evidence-first update explains apitegromab, bimagrumab, trevogrumab, taldefgrobep alfa, and older failed candidates.
Best Myostatin Inhibitor: Ranking Options by Evidence, Not Hype
The best myostatin inhibitor depends on the goal. This evidence-led ranking separates training, creatine, epicatechin, drugs, peptides, and supplement marketing.
Myostatin Blocker Claims: What Counts as Real?
A myostatin blocker is only useful if it changes the pathway and improves real outcomes. Here is what counts, what is indirect, and what is marketing.
Myostatin Inhibitor Supplement Claims: What Has Evidence?
Myostatin inhibitor supplement claims often sound stronger than the evidence. This buyer-safe review grades creatine, protein, epicatechin, HMB, vitamin D, and more.
What Is Myostatin? Function, Muscle Growth, and Why It Matters
Myostatin is the body’s muscle-growth brake. Here is what it does, why low myostatin matters, and where the claims get ahead of the evidence.
Myostatin Inhibitors: Drugs, Supplements, Natural Options, and Evidence
Myostatin inhibitors range from clinical antibodies to supplement claims. This evidence-first guide separates drugs, natural options, peptides, and hype.